Didier Raoult

InstitutionIHU-Méditerranée Infection
AddressMarseille
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 74 Covid-19 publications, with a maximum of 9 publications in March 2020 and Spetember 2020
    All Publications
    Bar chart showing 2678 publications over 31 distinct years, with a maximum of 252 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Brouqui P, Colson P, Melenotte C, Houhamdi L, Bedotto M, Devaux C, Gautret P, Gautret P, Million M, Parola P, Stoupan D, La Scola B, Lagier JC, Raoult D. COVID-19 re-infection. Eur J Clin Invest. 2021 Mar 06; e13537. PMID: 33675046.
      Citations:    Fields:    
    2. Edouard S, Jaafar R, Orain N, Parola P, Colson P, La Scola B, Fournier PE, Raoult D, Drancourt M. Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies. Eur J Clin Microbiol Infect Dis. 2021 Mar 03. PMID: 33660134.
      Citations:    Fields:    
    3. Hache G, Rolain JM, Gautret P, Deharo JC, Brouqui P, Raoult D, Honoré S. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity. Microb Drug Resist. 2021 Mar; 27(3):281-290. PMID: 33729874.
      Citations:    Fields:    
    4. Devaux CA, Lagier JC, Raoult D. New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness. Front Med (Lausanne). 2021; 8:640073. PMID: 33681266.
      Citations:    
    5. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Correction to: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2021 Feb 16; 12(1):21. PMID: 33594500.
      Citations:    
    6. Gautret P, Hoang VT, Colson P, Raoult D. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann. Int J Antimicrob Agents. 2021 Mar; 57(3):106306. PMID: 33596459.
      Citations:    Fields:    Translation:Humans
    7. Dubourg G, Lagier JC, Brouqui P, Casalta JP, Jacomo V, La Scola B, Rolain JM, Raoult D. Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients? J Microbiol Immunol Infect. 2021 Feb 13. PMID: 33632620.
      Citations:    Fields:    
    8. Ly TDA, Hoang VT, Goumballa N, Louni M, Canard N, Dao TL, Medkour H, Borg A, Bardy K, Esteves-Vieira V, Filosa V, Davoust B, Mediannikov O, Fournier PE, Raoult D, Gautret P. Variations in respiratory pathogen carriage among a homeless population in a shelter for men in Marseille, France, March-July 2020: cross-sectional 1-day surveys. Eur J Clin Microbiol Infect Dis. 2021 Feb 13. PMID: 33580843.
      Citations:    Fields:    
    9. Devaux CA, Pinault L, Osman IO, Raoult D. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2? Front Public Health. 2020; 8:608765. PMID: 33643982.
      Citations:    
    10. Ly TDA, Nguyen NN, Hoang VT, Goumballa N, Louni M, Canard N, Dao TL, Medkour H, Borg A, Bardy K, Esteves-Vieira V, Filosa V, Davoust B, Mediannikov O, Fournier PE, Raoult D, Gautret P. Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March-April 2020. Int J Infect Dis. 2021 Feb 10; 105:1-6. PMID: 33578010.
      Citations:    Fields:    
    11. Colson P, Levasseur A, Gautret P, Fenollar F, Thuan Hoang V, Delerce J, Bitam I, Saile R, Maaloum M, Padane A, Bedotto M, Brechard L, Bossi V, Ben Khedher M, Chaudet H, Million M, Tissot-Dupont H, Lagier JC, Mboup S, Fournier PE, Raoult D. Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: An investigational study. Travel Med Infect Dis. 2021 Mar-Apr; 40:101980. PMID: 33535105.
      Citations:    Fields:    
    12. Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, Guis S, Barthelemy F, Habert P, Ceccaldi M, Million M, Raoult D, Cammilleri S, Eldin C. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021 Jan 26. PMID: 33501506.
      Citations: 1     Fields:    
    13. Boumaza A, Gay L, Mezouar S, Bestion E, Diallo AB, Michel M, Desnues B, Raoult D, La Scola B, Halfon P, Vitte J, Olive D, Mege JL. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis. J Infect Dis. 2021 Jan 25. PMID: 33493287.
      Citations: 2     Fields:    
    14. Fenollar F, Bouam A, Ballouche M, Fuster L, Prudent E, Colson P, Tissot-Dupont H, Million M, Drancourt M, Raoult D, Fournier PE. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19. J Clin Microbiol. 2021 01 21; 59(2). PMID: 33139420.
      Citations: 6     Fields:    Translation:Humans
    15. Nguyen NN, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jan 05. PMID: 33418020.
      Citations:    Fields:    
    16. Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect. 2021 Feb; 54(1):37-45. PMID: 33500211.
      Citations:    Fields:    Translation:Humans
    17. Gautret P, Lagier JC, Honoré S, Hoang VT, Colson P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited. Int J Antimicrob Agents. 2021 Jan; 57(1):106243. PMID: 33408014.
      Citations:    Fields:    Translation:Humans
    18. Gautret P, Hoang VT, Chaudet H, Lagier JC, Raoult D. Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load. Int J Antimicrob Agents. 2021 01; 57(1):106244. PMID: 33408015.
      Citations:    Fields:    Translation:Humans
    19. Million M, Roussel Y, Gautret P, Raoult D. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. Int J Antimicrob Agents. 2021 Jan; 57(1):106240. PMID: 33408019.
      Citations: 2     Fields:    Translation:Humans
    20. Gautret P, Honoré S, Lagier JC, Raoult D. Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236. PMID: 33408025.
      Citations: 1     Fields:    Translation:Humans
    21. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. Int J Antimicrob Agents. 2021 01; 57(1):106237. PMID: 33408027.
      Citations:    Fields:    Translation:Humans
    22. Gautret P, Hoang VT, Lagier JC, Raoult D. Response to advances statistical methods and designs for clinical trials for COVID-19. Int J Antimicrob Agents. 2021 01; 57(1):106235. PMID: 33408028.
      Citations:    Fields:    Translation:Humans
    23. Gautret P, Hoang VT, Lagier JC, Raoult D. Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes. Int J Antimicrob Agents. 2021 Jan; 57(1):106239. PMID: 33408029.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    24. Colson P, La Scola B, Lagier JC, Gautret P, Raoult D. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106238. PMID: 33408030.
      Citations:    Fields:    Translation:Humans
    25. Gautret P, Hoang VT, Honoré S, Roussel Y, Million M, Lagier JC, Raoult D. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241. PMID: 33408031.
      Citations:    Fields:    Translation:Humans
    26. Gautret P, Lagier JC, Honoré S, Hoang VT, Raoult D. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242. PMID: 33408033.
      Citations: 1     Fields:    Translation:Humans
    27. Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, Leone M, La Scola B, Devaux C, Gaubert JY, Mege JL, Vitte J, Melenotte C, Rolain JM, Parola P, Lagier JC, Brouqui P, Raoult D. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020 12; 16(12):1159-1184. PMID: 33356661.
      Citations: 1     Fields:    Translation:Humans
    28. Boschi C, Hoang VT, Giraud-Gatineau A, Ninove L, Lagier JC, La Scola B, Gautret P, Raoult D, Colson P. Coinfections with SARS-CoV-2 and other respiratory viruses in Southeastern France: A matter of sampling time. J Med Virol. 2021 04; 93(4):1878-1881. PMID: 33230812.
      Citations:    Fields:    Translation:HumansCells
    29. Million M, Giraud-Gatineau A, Lagier JC, Parola P, Gautret P, Raoult D. Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis. 2021 Jan-Feb; 39:101954. PMID: 33316396.
      Citations:    Fields:    Translation:Humans
    30. Haddad G, Bellali S, Fontanini A, Francis R, La Scola B, Levasseur A, Bou Khalil J, Raoult D. Rapid Scanning Electron Microscopy Detection and Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 and Other Respiratory Viruses. Front Microbiol. 2020; 11:596180. PMID: 33329483.
      Citations:    
    31. Castelli M, Maurin A, Bartoli A, Dassa M, Marchi B, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Cortaredona S, Jacquier A, Gaubert JY, Habert P. Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19. Insights Imaging. 2020 Nov 17; 11(1):117. PMID: 33201409.
      Citations:    
    32. Colson P, Finaud M, Levy N, Lagier JC, Raoult D. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. 2021 Apr; 82(4):84-123. PMID: 33207255.
      Citations: 1     Fields:    
    33. Ly TDA, Zanini D, Laforge V, Arlotto S, Gentile S, Mendizabal H, Finaud M, Morel D, Quenette O, Malfuson-Clot-Faybesse P, Midejean A, Le-Dinh P, Daher G, Labarriere B, Morel-Roux AM, Coquet A, Augier P, Parola P, Chabriere E, Raoult D, Gautret P. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020. Int J Antimicrob Agents. 2020 Dec; 56(6):106219. PMID: 33189890.
      Citations: 6     Fields:    Translation:Humans
    34. Edouard S, Colson P, Melenotte C, Di Pinto F, Thomas L, La Scola B, Million M, Tissot-Dupont H, Gautret P, Stein A, Brouqui P, Parola P, Lagier JC, Raoult D, Drancourt M. Evaluating the serological status of COVID-19 patients using an indirect immunofluorescent assay, France. Eur J Clin Microbiol Infect Dis. 2021 Feb; 40(2):361-371. PMID: 33179133.
      Citations: 7     Fields:    Translation:Humans
    35. Leger T, Jacquier A, Barral PA, Castelli M, Finance J, Lagier JC, Million M, Parola P, Brouqui P, Raoult D, Bartoli A, Gaubert JY, Habert P. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS One. 2020; 15(11):e0241407. PMID: 33141845.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    36. Brouqui P, Amrane S, Million M, Cortaredona S, Parola P, Lagier JC, Raoult D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021 Jan; 102:233-238. PMID: 33130200.
      Citations: 4     Fields:    Translation:Humans
    37. Raoult D. How useful is serology for COVID-19? Int J Infect Dis. 2021 01; 102:170-171. PMID: 33129960.
      Citations:    Fields:    
    38. Raoult D. Rational for meta-analysis and randomized treatment: the COVID-19 example. Clin Microbiol Infect. 2021 Jan; 27(1):6-8. PMID: 33098998.
      Citations: 2     Fields:    Translation:Humans
    39. Gautret P, Colson P, Lagier JC, Camoin-Jau L, Giraud-Gatineau A, Boudjema S, Finance J, Chaudet H, Raoult D. Different pattern of the second outbreak of COVID-19 in Marseille, France. Int J Infect Dis. 2021 Jan; 102:17-19. PMID: 33038556.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    40. Jaafar R, Aherfi S, Wurtz N, Grimaldier C, Hoang VT, Colson P, Raoult D, La Scola B. Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates. Clin Infect Dis. 2020 Sep 28. PMID: 32986798.
      Citations: 9     Fields:    
    41. Brouqui P, Giraud-Gatineau A, Raoult D. Critical reappraisal of remdesivir investigational trials in COVID-19. New Microbes New Infect. 2020 Nov; 38:100745. PMID: 33088576.
      Citations:    
    42. Million M, Roussel Y, Lagier JC, Raoult D. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clin Microbiol Infect. 2021 01; 27(1):132-133. PMID: 32980527.
      Citations: 1     Fields:    Translation:Humans
    43. Colson P, Esteves-Vieira V, Giraud-Gatineau A, Zandotti C, Filosa V, Chaudet H, Lagier JC, Raoult D. Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern France. Int J Infect Dis. 2020 Dec; 101:121-125. PMID: 32976991.
      Citations:    Fields:    Translation:HumansCells
    44. Francis R, Le Bideau M, Jardot P, Grimaldier C, Raoult D, Bou Khalil JY, Bou Khalil JY, La Scola B. High-speed large-scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled to high-content screening. Clin Microbiol Infect. 2021 Jan; 27(1):128.e1-128.e7. PMID: 32979576.
      Citations:    Fields:    Translation:HumansAnimalsCells
    45. Raoult D. Lancet gate: a matter of fact or a matter of concern. New Microbes New Infect. 2020 Nov; 38:100758. PMID: 32983540.
      Citations:    
    46. Roussel Y, Raoult D. First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2. New Microbes New Infect. 2020 Nov; 38:100759. PMID: 32983541.
      Citations:    
    47. Lalaoui R, Bakour S, Raoult D, Verger P, Sokhna C, Devaux C, Pradines B, Rolain JM. What could explain the late emergence of COVID-19 in Africa? New Microbes New Infect. 2020 Nov; 38:100760. PMID: 32983542.
      Citations:    
    48. Boudjema S, Finance J, Coulibaly F, Meddeb L, Tissot-Dupont H, Michel M, Lagier JC, Million M, Radulesco T, Michel J, Brouqui P, Raoult D, Fenollar F, Parola P. Olfactory and gustative disorders for the diagnosis of COVID-19. Travel Med Infect Dis. 2020 Sep - Oct; 37:101875. PMID: 32898703.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    49. Colson P, Tissot-Dupont H, Morand A, Boschi C, Ninove L, Esteves-Vieira V, Gautret P, Brouqui P, Parola P, Lagier JC, Zandotti C, Million M, La Scola B, Raoult D. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1983-1987. PMID: 32845413.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    50. Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Immune responses during COVID-19 infection. Oncoimmunology. 2020 08 25; 9(1):1807836. PMID: 32939324.
      Citations:    
    51. Aherfi S, Gautret P, Chaudet H, Raoult D, La Scola B. Clusters of COVID-19 associated with Purim celebration in the Jewish community in Marseille, France, March 2020. Int J Infect Dis. 2020 Nov; 100:88-94. PMID: 32829043.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    52. Brahim Belhaouari D, Fontanini A, Baudoin JP, Haddad G, Le Bideau M, Bou Khalil JY, Bou Khalil JY, Raoult D, La Scola B. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle. Front Microbiol. 2020; 11:2014. PMID: 32973730.
      Citations:    
    53. Dao TL, Hoang VT, Ly TDA, Goumballa N, Courjon J, Memish Z, Sokhna C, Raoult D, Parola P, Gautret P. Epidemiology of human common coronavirus acquisition in pilgrims. Travel Med Infect Dis. 2020 Sep - Oct; 37:101845. PMID: 32805418.
      Citations:    Fields:    Translation:HumansCells
    54. Javelle E, Raoult D. COVID-19 pandemic more than a century after the Spanish flu. Lancet Infect Dis. 2021 04; 21(4):e78. PMID: 32795410.
      Citations: 2     Fields:    
    55. Gautret P, Raoult D. Nullane salus extra ecclesiam. New Microbes New Infect. 2020 Sep; 37:100714. PMID: 32834899.
      Citations:    
    56. Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, Raoult D. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021 02; 48(2):592-595. PMID: 32728799.
      Citations: 8     Fields:    Translation:Humans
    57. Sokhna C, Mboup BM, Goumbala N, Dieng M, Sylla AB, Raoult D, Parola P, Gautret P. Establishing Medical Coverage and Epidemiological Surveillance during the Grand Magal of Touba in Senegal: A Public Health Need. J Epidemiol Glob Health. 2020 12; 10(4):247-249. PMID: 32959622.
      Citations:    Fields:    Translation:HumansPHPublic Health
    58. Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul - Aug; 36:101791. PMID: 32593867.
      Citations: 57     Fields:    Translation:HumansCellsPHPublic Health
    59. Million M, Roussel Y, Raoult D. Chloroquine and COVID-19: A western medical and scientific drift? Eur J Intern Med. 2020 08; 78:4-5. PMID: 32600860.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    60. Brouqui P, Giraud-Gatineau A, Raoult D. Remdesivir investigational trials in COVID-19: a critical reappraisal. New Microbes New Infect. 2020 Jun 07; 100707. PMID: 32837727.
      Citations:    
    61. Million M, Gautret P, Colson P, Roussel Y, Dubourg G, Dubourg G, Chabriere E, Honore S, Rolain JM, Fenollar F, Fournier PE, Lagier JC, Parola P, Brouqui P, Raoult D. Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world. New Microbes New Infect. 2020 Nov; 38:100709. PMID: 33088574.
      Citations:    
    62. Roussel Y, Raoult D. Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences. New Microbes New Infect. 2020 Nov; 38:100710. PMID: 33088575.
      Citations:    
    63. Gautret P, Colson P, Lagier JC, Parola P, Raoult D. Does spitting in public play a role in transmitting SARS-CoV-2? Travel Med Infect Dis. 2020 Jul - Aug; 36:101759. PMID: 32492484.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    64. Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA. SARS-CoV-2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e304-e306. PMID: 32330336.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    65. Giraud-Gatineau A, Colson P, Jimeno MT, Zandotti C, Ninove L, Boschi C, Lagier JC, La Scola B, Chaudet H, Raoult D. Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year in Southeastern France. Int J Infect Dis. 2020 Jul; 96:154-156. PMID: 32389848.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    66. Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020 Jun; 53(3):425-435. PMID: 32414646.
      Citations: 77     Fields:    Translation:HumansCellsPHPublic Health
    67. Morand A, Roquelaure B, Colson P, Amrane S, Bosdure E, Raoult D, Lagier JC, Fabre A. Child with liver transplant recovers from COVID-19 infection. A case report. Arch Pediatr. 2020 Jul; 27(5):275-276. PMID: 32402433.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    68. Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, Aubry C, Correard F, Giraud-Gatineau A, Roussel Y, Berenger C, Cassir N, Seng P, Zandotti C, Dhiver C, Ravaux I, Tomei C, Eldin C, Tissot-Dupont H, Honoré S, Stein A, Jacquier A, Deharo JC, Chabrière E, Levasseur A, Fenollar F, Rolain JM, Obadia Y, Brouqui P, Drancourt M, La Scola B, Parola P, Raoult D. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738. PMID: 32387409.
      Citations: 130     Fields:    Translation:HumansCellsPHPublic Health
    69. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, Gautret P, Raoult D. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1059-1061. PMID: 32342252.
      Citations: 108     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    70. Andreani J, Le Bideau M, Duflot I, Jardot P, Rolland C, Boxberger M, Wurtz N, Rolain JM, Colson P, La Scola B, Raoult D. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020 Aug; 145:104228. PMID: 32344177.
      Citations: 67     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    71. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M, Eldin C, Finance J, Vieira VE, Tissot-Dupont HT, Honoré S, Stein A, Million M, Colson P, La Scola B, Veit V, Jacquier A, Deharo JC, Drancourt M, Fournier PE, Rolain JM, Brouqui P, Raoult D. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar - Apr; 34:101663. PMID: 32289548.
      Citations: 228     Fields:    Translation:HumansCellsPHPublic Health
    72. Colson P, Lagier JC, Baudoin JP, Bou Khalil J, Bou Khalil J, La Scola B, Raoult D. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020 Aug; 39(8):1601-1603. PMID: 32270412.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    73. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul; 56(1):105949. PMID: 32205204.
      Citations: 1555     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    74. Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, Dudouet P, Ormières E, Ailhaud L, Parola P, Lagier JC, Brouqui P, Zandotti C, Ninove L, Luciani L, Boschi C, La Scola B, Raoult D, Million M, Colson P, Gautret P. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot. Travel Med Infect Dis. 2020 Jul - Aug; 36:101632. PMID: 32205269.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    75. Roussel Y, Giraud-Gatineau A, Jimeno MT, Rolain JM, Zandotti C, Colson P, Raoult D. SARS-CoV-2: fear versus data. Int J Antimicrob Agents. 2020 May; 55(5):105947. PMID: 32201354.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    76. Lagier JC, Colson P, Tissot Dupont H, Salomon J, Doudier B, Aubry C, Gouriet F, Baron S, Dudouet P, Flores R, Ailhaud L, Gautret P, Parola P, La Scola B, Raoult D, Brouqui P. Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis. 2020 Mar - Apr; 34:101624. PMID: 32179125.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    77. Baron SA, Devaux C, Colson P, Raoult D, Rolain JM. Teicoplanin: an alternative drug for the treatment of COVID-19? Int J Antimicrob Agents. 2020 Apr; 55(4):105944. PMID: 32179150.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic Health
    78. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May; 55(5):105938. PMID: 32171740.
      Citations: 303     Fields:    Translation:HumansCellsPHPublic Health
    79. Raoult D, Hsueh PR, Stefani S, Rolain JM. COVID-19 Therapeutic and Prevention. Int J Antimicrob Agents. 2020 04; 55(4):105937. PMID: 32151714.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    80. Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 04; 55(4):105932. PMID: 32145363.
      Citations: 270     Fields:    Translation:CellsPHPublic Health
    81. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020 Mar 02; 4(4):66-75. PMID: 32292881.
      Citations:    
    82. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020 03; 55(3):105923. PMID: 32070753.
      Citations: 140     Fields:    Translation:AnimalsCellsPHPublic Health
    83. Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, Gazin C, Bedotto M, Filosa V, Giraud-Gatineau A, Chaudet H, Brouqui P, Lagier JC, Raoult D. Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8). PMID: 32127122.
      Citations: 4     Fields:    Translation:HumansCells
    84. Hoang VT, Ali-Salem S, Belhouchat K, Meftah M, Sow D, Dao TL, Ly TDA, Drali T, Ninove L, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Respiratory tract infections among French Hajj pilgrims from 2014 to 2017. Sci Rep. 2019 11 28; 9(1):17771. PMID: 31780750.
      Citations: 5     Fields:    Translation:Humans
    85. Hoang VT, Sow D, Belhouchat K, Dao TL, Ly TDA, Fenollar F, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Environmental investigation of respiratory pathogens during the Hajj 2016 and 2018. Travel Med Infect Dis. 2020 Jan - Feb; 33:101500. PMID: 31600567.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    86. Hoang VT, Goumballa N, Dao TL, Ly TDA, Ninove L, Ranque S, Raoult D, Parola P, Sokhna C, Pommier de Santi V, Gautret P. Respiratory and gastrointestinal infections at the 2017 Grand Magal de Touba, Senegal: A prospective cohort survey. Travel Med Infect Dis. 2019 May 03; 101410. PMID: 31048009.
      Citations: 7     Fields:    
    87. Hoang VT, Sow D, Dogue F, Edouard S, Drali T, Yezli S, Alotaibi B, Raoult D, Parola P, Pommier de Santi V, Gautret P. Acquisition of respiratory viruses and presence of respiratory symptoms in French pilgrims during the 2016 Hajj: A prospective cohort study. Travel Med Infect Dis. 2019 Jul - Aug; 30:32-38. PMID: 30858034.
      Citations: 6     Fields:    Translation:HumansCells
    88. Hoang VT, Dao TL, Ly TDA, Belhouchat K, Chaht KL, Gaudart J, Mrenda BM, Drali T, Yezli S, Alotaibi B, Fournier PE, Raoult D, Parola P, de Santi VP, Gautret P. The dynamics and interactions of respiratory pathogen carriage among French pilgrims during the 2018 Hajj. Emerg Microbes Infect. 2019; 8(1):1701-1710. PMID: 31749410.
      Citations: 7     Fields:    Translation:HumansCells
    89. Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, Memish ZA, Al Masri M, Fournier PE, Raoult D, Brouqui P, Parola P, Gautret P. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis. 2014 Nov; 20(11):1821-7. PMID: 25341199.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    90. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, Salez N, Memish ZA, Al Masri M, Lagier JC, Million M, Raoult D, Brouqui P, Parola P. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014 Apr; 20(4):728-30. PMID: 24656283.
      Citations: 37     Fields:    Translation:HumansCells
    91. Raoult D. Recent and future developments in the epidemiology of the infectious diseases. Eur J Epidemiol. 2009; 24(8):393-5. PMID: 19533385.
      Citations: 3     Fields:    Translation:Humans
    Raoult's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (2770)
    Explore
    _
    Co-Authors (748)
    Explore
    _
    Similar People (60)
    Explore
    _